Chemotherapy-induced alopecia: Psychosocial impact and therapeutic approaches

Supportive Care in Cancer

Volumn 12, Issue 8, 2004, Pages 543-549

  Hesketh, Paul J ^a   Batchelor, Diane ^b   Golant, Mitch ^c   Lyman, Gary H ^d   Rhodes, Nelson ^e   Yardley, Denise ^f  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b Cancer Centre of South Eastern Ontario   (Canada)

^c Wellness Community   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e GLAXOSMITHKLINE   (United States)

^f SARAH CANNON RESEARCH INSTITUTE   (United States)

Author keywords

Alopecia; Cancer; Chemotherapy; Psychological; Quality of life; Supportive care

Indexed keywords

ALTRETAMINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; IFOSFAMIDE; MELPHALAN; MERCAPTOPURINE; MITOMYCIN; PACLITAXEL; STREPTOZOCIN; THIOTEPA; TIOGUANINE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE; VINDESINE;

ALOPECIA; ANXIETY DISORDER; BODY IMAGE; DEPRESSION; EDUCATION; HAIR LOSS; HUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SELF CARE; SELF ESTEEM; SIDE EFFECT; SOCIAL ASPECT; SUPPORT GROUP; WELLBEING;

EID: 4043087953     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-003-0562-5     Document Type: Review

References (51)

1. Batchelor D (2001) Hair and cancer chemotherapy: consequences and nursing care-a literature study. Eur J Cancer Care 10:147-163
2. Botchkarev VA, Komarova EA, Siebenhaar F, Botchkareva NV, Komarov PG, Maurer M, Gilchrest BA, Gudkov AV (2000) p53 is essential for chemotherapy-induced hair loss. Cancer Res 60:5002-5006
3. Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95:155-163
4. Cassileth B, Zupikis R, Sutton-Smith K, March V (1980) Information and participation preferences among cancer patients. Ann Intern Med 92:832-836
5. Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34:13-19
6. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11:570-579
7. Christodoulou C, Klouvas G, Efstathiou E, Zervakis D, Papazachariou E, Plyta M, Skarlos DV (2002) Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia. Oncology 62:97-102
8. Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MH (1983) On the receiving end-patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203-208
9. Cordova M, Giese-Davis J, Golant M, Kronenwetter C, Spiegel D (2003) Presented at the Society of Behavioral Medicine, 24th Annual Meeting and Scientific Sessions, Salt Lake City, Utah, USA, March 19-22, 2003
10. Cotsarelis G, Millar S (2001) Towards a molecular understanding of hair loss and its treatment. Trends Mol Med 7:293-301
11. de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, Verweij J (1997) Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 76:1055-1061
12. Dean JC, Salmon SE, Griffith KS (1979) Prevention of doxorubicin-induced hair loss with scalp hypothermia. N Engl J Med 301:1427-1429
13. Duvic M, Lemak NA, Valero V, Hymes SR, Farmer KL, Hortobagyi GN, Trancik RJ, Bandstra BA, Compton LD (1996) A randomized trial of minoxidil in chemotherapy-induced alopecia. J Am Acad Dermatol 35:74-78
14. Fallowfield L (1992) Behavioural interventions and psychological aspects of care dufing during chemotherapy. Eur J Cancer 28A:S39-S41
15. Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, Tattersall MH (1996) On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189-195
16. Hennessey JD (1966) Alopecia and cytotoxic drugs. Br Med J 2:1138
17. Hidalgo M, Rinaldi D, Medina G, Griffin T, Turner J, Von Hoff DD (1999) A phase I trial of topical topitriol (calcitriol, 1,25-dihydroxyvitamin D3) to prevent chemotherapy-induced alopecia. Anticancer Drugs 10:393-395
18. Hillen HF, Breed WP, Botman CJ (1990) Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia. Neth J Med 37:231-235
19. Horowitz M, Wilner N, Alvarez W (1979) Impact of Event Scale: a measure of subjective stress. Psychosom Med 41:209-218
20. Hussein AM (1995) Protection against cytosine arabinoside-induced alopecia by minoxidil in a rat animal model. Int J Dermatol 34:470-473
21. Hussein AM, Stuart A, Peters WP (1995) Protection against chemotherapy-induced alopecia by cyclosporin A in the newborn rat animal model. Dermatology 190:192-196
22. Jimenez JJ, Yunis AA (1992) Protection from chemotherapy-induced alopecia by 1,25-dihydroxyvitamin D3. Cancer Res 52:5123-5125
23. Johansen LV (1985) Scalp hypothermia in the prevention of chemotherapy-induced alopecia. Acta Radiologica 24:113-116
24. Katsimbri P, Bamias A, Pavlidis N (2000) Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 36:766-771
25. Keller J, Blausey L (1988) Nursing issues and management in chemotherapy-induced alopecia. Oncol Nurs Forum 15:603-607
26. Kennedy M, Packard R, Grant M, Padilla G, Presant C, Chillar R (1983) The effects of using Chemocap on occurrence of chemotherapy-induced alopecia. Oncol Nurs Forum 10:19-24
27. Kiebert GM, Hanneke J, de Haes CJ, Kievit J, van de Velde CJ (1990) Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer. Eur J Cancer 26:1038-1042
28. Lieberman MA, Golant M, Giese-Davis J, Winzelberg A, Benjamin H, Humphreys K, Kronenwetter C, Russo S, Spiegel D (2003) Electronic support groups for breast carcinoma. Cancer 97:920-925
29. Maurer M, Handjiski B, Paus R (1997) Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia. Am J Pathol 150:1433-1441
30. McGarvey EL, Baum LD, Pinkerton RC, Rogers LM (2001) Psychological sequelae and alopecia among women with cancer. Cancer Pract 9:283-289
31. Muller-Rover S, Rossiter H, Lindner G, Peters EM, Kupper TS, Paus R (1999) Hair follice apoptosis and Bcl-2. J Investig Dermatol Symp Proc 4:272-277
32. Munstedt K, Manthey N, Sachsse S, Vahrson H (1997) Changes in self-concept and body image during alopecia induced cancer chemotherapy. Support Care Cancer 5:139-143
33. Paus R, Cotsarelis G (1999) The biology of hair follicles. N Engl J Med 341:491-497
34. Paus R, Schilli MB, Handjiski B, Menrad A, Henz BM, Plonka P (1996) Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice. Cancer Res 56:4438-4443
35. Perlin E, Amin D (1991) Protection from chemotherapy-induced alopecia. Med Pediatr Oncol 19:129-130
36. Pesce A, Cassuto JP, Joyner MV, DuJardin P, Audoly P (1978) Scalp toumiquet in the prevention of chemotherapy-induced alopecia. N Engl J Med 298:1204-1205
37. Peters EM, Foitzik K, Paus R, Ray S, Holick MF (2001) A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist. J Invest Dermatol 117:173-178
38. Pickard-Holley S (1995) The symptom experience of alopecia. Semin Oncol Nurs 11:235-238
39. Pozo-Kaderman C, Kaderman R, Toonkel R (1999) The psychosocial aspects of breast cancer. Nurse Pract Forum 10:165-174
40. Protiere C, Evans K, Camerlo J, d'Ingrado M, Macquart-Moulin G et al (2002) Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy. Support Care Cancer 10:529-537
41. Rhodes V, McDaniel R, Johnson M (1995) Patients education: self-care guides. Semin Oncol Nurs 11:298-304
42. Ridderheim M, Bjurberg M, Gustavsson A (2003) Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 11:371-377
43. Rodriguez R, Machiavelli M, Leone B, Romero A, Cuevas MA, Langhi M, Romero Acuna L, Romero Acuna J, Amato S, Barbieri M, et al (1994) Minoxidil (Mx) as a prophylaxis of doxorubicin-induced alopecia. Ann Oncol 5:769-70
44. Sitzia J, Hughes J, Sobrido L (1993) A study of patients' experience of side-effects associated with chemotherapy: pilot stage report. Int J Nurs Stnd 32:580-600
45. Takahata K, Tada M, Yazawa K, Tamaki T (1999) Protection from chemotherapy-induced alopecia by docosahexaenoic acid. Lipids 34:S105
46. Tierney AJ (1987) Preventing chemotherapy-induced alopecia in cancer patients: is scalp cooling worthwhile? J Adv Nurs 12:303-310
47. Tierney A, Taylor J (1991) Chemotherapy-induced hair loss. Nurs Stand 5:29-31
48. Tsuda T, Ohmori Y, Muramatsu H, Hosaka Y, Takiguchi K, Saitoh F, Kato K, Nakayama K, Nakamura N, Nagata S, Mochizuki H (2001). Inhibitory effect of M50054, a novel inhibitor of apoptosis, on anti-Fas-antibody-induced hepatitis and chemotherapy-induced alopecia. Eur J Pharmacol 433:37-45
49. Wheelock JB, Myers MB, Krebs HB, Goplerud DR (1984) Ineffectiveness of scalp hypothermia in the prevention of alopecia in patients treated with doxorubicin and cisplatin combinations. Cancer Treat Rep 68:1387-1388
50. Whelan T, Rath D, Willan A, Neimanis M, Czukar D, Levine M (1998) Evaluation of a patient file folder to improve the dissemination of written information materials for cancer patients. Cancer 83:1620-1625
51. Williams J, Wood C, Cunningham-Warburton P (1999) A narrative study of chemotherapy-induced alopecia. Oncol Nurs Forum 26:1463-1468